Relapse after allogeneic hematopoietic stem cell transplant in patients with chronic myeloid leukemia: tyrosine kinase inhibitors, donor lymphocyte infusions or both?

Leuk Lymphoma. 2015;56(10):2995-6. doi: 10.3109/10428194.2015.1026819. Epub 2015 Mar 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Combined Modality Therapy
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Lymphocyte Transfusion
  • Protein Kinase Inhibitors / therapeutic use
  • Recurrence
  • Transplantation, Homologous
  • Treatment Outcome

Substances

  • Protein Kinase Inhibitors